IP
GYRE icon

Intellectus Partners’s Gyre Therapeutics GYRE Stock Holding History

Intellectus Partners’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Hold
0
– – – 372
2018
Q3 		– Sell
-9
Closed -$713 – 590
2018
Q2 		$1K Hold
9
– – ﹤0.01% 575
2018
Q1 		$2K Hold
9
– – ﹤0.01% 565
2017
Q4 		$1K Hold
9
– – ﹤0.01% 599
2017
Q3 		$0 Hold
9
– – ﹤0.01% 787
2017
Q2 		$0 Hold
9
– – ﹤0.01% 776
2017
Q1 		$1K Sell
9
-830
-99% -$48.5K ﹤0.01% 670
2016
Q4 		$61K Buy
+839
New +$75.5K 0.03% 288

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return